Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Blueprint Medi Cm ST (BPMC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,397,811
  • Shares Outstanding, K 42,880
  • Annual Sales, $ 27,770 K
  • Annual Income, $ -72,500 K
  • 36-Month Beta 1.29
  • Price/Sales 100.62
  • Price/Cash Flow N/A
  • Price/Book 9.08

Price Performance

See More
Period Period Low Period High Performance
1-Month
70.83 +11.16%
on 12/19/17
84.44 -6.76%
on 01/03/18
+3.61 (+4.80%)
since 12/15/17
3-Month
61.58 +27.86%
on 11/15/17
92.00 -14.42%
on 12/11/17
+14.57 (+22.72%)
since 10/16/17
52-Week
31.35 +151.15%
on 01/18/17
92.00 -14.42%
on 12/11/17
+46.23 (+142.19%)
since 01/13/17

Most Recent Stories

More News
Will Intuitive Surgical (ISRG) Disappoint in Q4 Earnings?

Intuitive Surgical (ISRG) is expected to witness growth across da Vinci Surgical and Service segments. Instruments and accessories revenues are also expected to increase year over year.

CNC : 110.20 (+0.66%)
BPMC : 79.04 (-0.25%)
ISRG : 423.30 (+1.02%)
EIGR : 8.55 (-46.56%)
Factors of Influence in 2018, Key Indicators and Opportunity within Barrett Business Services, Tech Data, Approach Resources, ICF International, Blueprint Medicines, and Government Properties Income Trust -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Barrett Business Services,...

TECD : 105.52 (+0.64%)
BBSI : 66.16 (+0.93%)
AREX : 3.86 (-1.28%)
BPMC : 79.04 (-0.25%)
ICFI : 55.40 (+2.03%)
GOV : 17.82 (+0.73%)
Watch for Blueprint Medici to Potentially Pullback After Gaining 3.98% Yesterday

Blueprint Medici (NASDAQ:BPMC) traded in a range yesterday that spanned from a low of $76.52 to a high of $81.40. Yesterday, the shares gained 4.0%, which took the trading range above the 3-day high...

BPMC : 79.04 (-0.25%)
Blueprint Medicines Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common Stock

Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced the closing of its previously...

BPMC : 79.04 (-0.25%)
Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock

Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced the pricing of an underwritten...

BPMC : 79.04 (-0.25%)
Company News For Dec 12, 2017

Companies in the news are: KMG,ARGX,BPMC,BLUE

KMG : 65.29 (-0.71%)
BLUE : 163.48 (-4.23%)
BPMC : 79.04 (-0.25%)
ARGX : 69.15 (-1.94%)
Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock

Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced that it has commenced an...

BPMC : 79.04 (-0.25%)
Merrimack Announces Appointment of George Demetri, M.D., to Board of Directors

Merrimack Pharmaceuticals (NASDAQ: MACK) today announced the addition of George Demetri, M.D., a professor of medicine at Harvard Medical School and physician-scientist faculty member at the Dana-Farber...

BPMC : 79.04 (-0.25%)
MACK : 10.53 (-1.96%)
Featured Company News - Blueprint Medicines Announced New Data from Ongoing Phase-1 Trial of BLU-285 in Patients with Advanced Gastrointestinal Stromal Tumors

Research Desk Line-up: Puma Biotechnology Post Earnings Coverage

PBYI : 95.00 (-4.28%)
BPMC : 79.04 (-0.25%)
Blueprint Medicines Announces New Data from Ongoing Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Gastrointestinal Stromal Tumors Showing Strengthened Clinical Activity across Spectrum of KIT and PDGFRa Genotypes

Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced new Phase 1 clinical data...

BPMC : 79.04 (-0.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Blueprint Medicines Corp is an oncology company which is engaged in developing kinase inhibitors for genomically defined cancer subsets. Blueprint Medicines Corp is based in Cambridge, MA.

See More

Key Turning Points

2nd Resistance Point 82.21
1st Resistance Point 80.73
Last Price 79.04
1st Support Level 77.02
2nd Support Level 74.79

See More

52-Week High 92.00
Last Price 79.04
Fibonacci 61.8% 68.83
Fibonacci 50% 61.67
Fibonacci 38.2% 54.52
52-Week Low 31.35

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.